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A.	Introducton	
	The	number	of	patients	with	diabetes	has	increased,	partly	due	to	changes	
in	dietary	habits	and	a	lack	of	exercise1-3.	Diabetes	leads	to	an	array	of	
additional	complications	and	as	such,	the	disease	and	its	prevention	have	
become	a	worldwide	priority4.	One	of	the	major	complications	of	diabetes	
is	diabetic	nephropathy	(DN),	the	leading	cause	of	end-stage	renal	disease	
(ESRD)	5,6.	Several	studies	have	shown	that	the	diabetic	kidney	is	exposed	
to	environmental	stressors	that	may	cause	endoplasmic	reticulum	(ER)	
stress5,6.	
	The	ER	is	the	major	site	responsible	for	the	folding,	maturation,	and	
trafficking	of	most	secretory	and	membrane	proteins7,8.	When	nascent	protein	
loading	exceeds	the	ER	folding	capacity	in	circumstances	such	as	a	virus	
infection,	gene	mutation,	calcium	flux	perturbation,	or	glucose	
deprivation,	the	unfolded	protein	response	(UPR)	is	activated	to	suppress	
protein	synthesis	and	increase	both	the	ER	folding	capacity	and	the	
degradation	of	misfolded	proteins,	thereby	restoring	cellular	homeostasis7.	
However,	if	the	stress	response	is	prolonged	or	beyond	the	adaptive	range,	
it	may	also	lead	to	cell	death7.	
	UPR	is	mediated	by	three	canonical	pathways:	RNA-dependent	protein	
kinase-like	ER	kinase	(PERK),	activating	transcription	factor	6	(ATF6),	
and	inositol-requiring	enzyme	1	(IRE1)7.	PERK	is	an	ER-resident	type	I	
transmembrane	protein	kinase7,9.	PERK	phosphorylation	at	Ser51	of	
eukaryotic	translation	initiation	factor	2α	(eIF2α)	inhibits	
cap-dependent	protein	translation	with	the	notable	exception	of	activating	
transcription	factor	4	(ATF4)7,9.	As	a	transcription	factor,	ATF4	activated	
by	phosphorylation	of	eIF2α	in	turn	promotes	the	transcription	of	
CCAAT/enhancer-binding	protein	homologous	protein	(Chop/Gadd153),	which	
is	important	in	ER	stress-induced	apoptosis	and	regulates	calcium	signaling	
and	cytochrome	c	release	from	the	mitochondria7,9,10.	ATF6	is	initially	
located	in	the	ER	as	a	type	II	transmembrane	protein	and,	under	stress	
conditions,	ATF6	is	transferred	to	the	golgi	bodies,	where	it	is	cleaved	
by	site-1	and	site-2	proteases7,11.	The	cleaved	N-terminal	ATF6	fragment	
enters	the	nucleus	and	increases	the	transcription	of	adaptive	chaperons,	
such	as	Bip/GRP787,11.	IRE1	is	a	type	I	transmembrane	protein	with	both	
endoribonuclease	and	kinase	activities7,12.	The	endoribonuclease	activity	
of	IRE1	cleaves	a	26-nucleotide	intron	from	the	X-box	binding	protein	1	
(XBP1)	to	generate	the	spliced	XBP1	(XBP1s),	a	potent	transcription	factor	
that	participates	in	the	pro-survival	response	but	whose	activity	declines	
during	prolonged	progression	of	ER	stress7,12.	
	It	has	been	shown	that	the	IRE1α-XBP1	pathway	is	related	to	insulin	
resistance	by	activating	JNK	and	suppressing	insulin	signaling,	but	the	
relationship	between	ER	stress	and	diabetic	complications	is	still	largely	
unknown13-15.	Ceramides	are	important	molecules	participating	in	the	
sphingolipid	metabolism	and	play	critical	roles	in	the	regulation	of	
various	cellular	functions,	including	cell	proliferation,	differentiation,	
migration,	and	apoptosis16,17.	In	particular,	the	short	side	chain	C2	
ceramide	easily	invades	into	cells	and	shows	physiological	activity	and	
enhances	caspase-dependent	apoptosis17.	Plasma	C2	ceramide	levels	also	
increase	in	diabetes18.	
	Glomerular	damage	is	considered	the	main	characteristic	in	the	kidneys	
of	patients	with	DN.	However	more	recently	it	was	suggested	that	alterations	
in	the	renal	tubule	might	also	contribute	to	the	pathogenesis	of	DN20.	
Interestingly,	the	novel	type	2	diabetes	drug	dapagliflozin	reduces	blood	
glucose	and	body	weight	by	inhibiting	sodium	glucose	transporter	2	(SGLT2)	
in	the	proximal	tubular	cells19.	We	hypothesized	that	modulation	of	SGLT2	
activity	might	change	the	glucose	influx	inside	renal	tubular	cells.	
Inhibiting	SGLT2	with	dapagliflozin	may	regulate	the	metabolic	conditions	
that	cause	ER	stress	in	these	cells21.	Therefore,	in	this	study,	we	examined	
the	effect	of	the	SGLT2	inhibitor,	dapagliflozin,	on	UPR	in	the	HK-2	
proximal	tubular	cell	line	and	in	vivo.	
	
B.	Materials	and	Methods	
Antibodies	and	reagents	
	Dapagliflozin	and	C2	ceramide	were	purchased	from	Cayman	Chemical	
	(Ann	Arbor,	MI,	USA)	and	SIGMA-ALDRICH	(St.	Louis,	MO,	USA)	respectively.	
Rabbit	polyclonal	anti-elf2α	and	anti-phospho-elf2α	Ser51)	antibodies	
were	from	Cell	Signaling	Technology	Inc.	(Boston,	MA,	USA).	
Rabbit	polyclonal	anti-IRE1α	and	anti-phospho-IRE1α,	and	mouse	
monoclonal	anti-ATF6	antibodies	were	from	Novus	Biologicals	(Littleton,	
CO,	USA).	Mouse	monoclonal	anti-GAPDH	antibody	was	from	MBL	(Woods	Hole,	
MA,	USA).	All	other	reagents	were	purchased	from	Sigma-Aldrich.	
Culture	and	drug	treatment	in	vitro	
	The	human	renal	proximal	tubular	epithelial	cell	line	HK-2	was	obtained	
from	ATCC	(Manassas,	VA,	USA).	The	cells	were	cultured	in	a	100-cm2	dish	
and	grown	at	37°C	in	an	atmosphere	of	5%	CO2	in	air	in	Keratinocyte-SFM	
medium	supplemented	with	bovine	pituitary	extract	(0.05	mg/ml)	and	
epithelial	growth	factor	(5ng/ml;	Gibco,	Carlsbad,	CA,	USA).	The	cells	were	
subcultured	when	they	reached	70–80%	confluence.	Twenty-four	hours	after	
reseeding,	the	cells	were	treated	either	with	dimethyl	sulfoxide	or	2μM	
dapagliflozin	in	a	serum-free	culture	medium	for	24-48	h.	Since	the	effect	
of	dapagliflozin	was	fully	regulated	under	confluent	conditions,	every	
experiment	was	performed	at	confluence.		
Animals	
	Animals	were	housed	in	a	facility	with	a	12-h	light/dark	cycle	and	fed	
ad	libitum	with	a	standard	chow	diet	(Research	Diets,	New	Brunswick,	NJ)	
containing	67%	(Kcal)	carbohydrates,	19%	protein,	and	4%	fat.	All	studies	
were	approved	by	and	performed	in	compliance	with	the	guidelines	of	the	
institutional	animal	care	and	use	committee	of	Gunma	University.	db/db	mice	
were	purchased	from	Charles	River	and	acclimatized	for	2	weeks.	
Dapagliflozin	(0.5	mg/kg/day)	dissolved	with	0.5%	methylcellulose	was	
orally	administered	every	day	for	1	week.	The	mice	were	sacrificed	by	
cerebral	dislocation	and	kidneys	were	collected	after	fasting	by	16	h	
followed	by	4-h	refeeding.	
Western	blot	analysis	
	Proteins	were	extracted	using	a	lysis	buffer	containing	a	protease	
inhibitor	as	described	previously	and	quantified	using	a	BCA	protein	assay	
kit	(Pierce,	Rockford,	IL,	USA).	Equal	amounts	of	protein	were	separated	
using	10%	sodium	dodecyl	sulfate–polyacrylamide	gel	electrophoresis	(SDS–
PAGE)	and	electrophoretically	transferred	onto	nitrocellulose	membranes,	
which	were	blocked	with	5%	fatty	acid-free	powdered	milk	for	1	h.	The	
membranes	were	incubated	with	the	following	primary	antibodies	overnight	
at	4°C:	anti-p-elf2α	(1:500),	anti-elf2α	(1:1000),	anti-IRE1	(1:1000),	
anti-p-IRE1	(1:1000),	anti-	ATF6	(1:200),	and	anti-GAPDH	(1:1000),	
followed	by	incubation	with	HRP280	conjugated	secondary	antibody	for	30	
min.	The	membranes	were	extensively	washed	in	TBST,	and	antigen-antibody	
complexes	were	visualized	by	chemiluminescence	using	an	ECL	kit	(Pierce).	
RNA	isolation	and	real-time	qPCR	
	Total	RNA	was	isolated	from	cells	and	tissues	using	the	RNeasy	Plus	Mini	
Kit	(Qiagen,	Valencia,	CA,	USA)	according	to	the	manufacturer's	protocol.	
Total	RNA	(1000μg)	was	reverse-transcribed	using	the	SuperScript	VILO	cDNA	
Synthesis	Kit	(Invitrogen,	Carlsbad,	CA,	USA).	Real-time	quantitative	PCR	
was	performed	on	an	Applied	Biosystems	7500HT	(Applied	Biosystems,	
Branchburg,	NJ,	USA)	with	Eagle	taq	Master	Mix	(Roche	Lifescience).	Gene	
expression	levels	of	CHOP,	ATF4,	and	SGLT2	were	internally	normalized	
against	that	of	βactin	and	analyzed	by	a	standard	curve	method.	Each	
experiment	was	performed	in	triplicate	and	repeated	three	times.	
Measurement	of	glucose	concentrations	in	HK2	cells	
	Glucose	concentration	was	measured	using	the	PicoProbe	Glucose	
Fluorometric	Assay	Kit	(BioVision,	Milpitas,	CA,	USA).	In	brief,	cells	were	
lysed	and	proteins	were	incubated	with	the	reagents	provided.	Samples	were	
transferred	to	black-bottom	96-well	microplates,	and	glucose	
concentrations	were	read	at	excitation	and	emission	wavelengths	of	535	and	
587	nm,	respectively,	in	a	fluorescence	microplate	reader	(EnSpire,	Perkin	
Elmer).	Control	reactions	were	carried	out	with	no	protein	and/or	no	
substrate.	
Measurement	of	caspase-3	activities	in	HK2	cells	
	Caspase-3	activity	was	measured	using	a	Caspase-3	Fluorescence	Assay	
Kit	(MBL)	according	to	manufacturer's	instructions.	Briefly,	cells	and	
tissues	were	lysed	and	proteins	were	incubated	with	the	caspase-3	substrate	
DEVD	AMC	(2μM)	for	1	h	at	37	°C.	Samples	were	transferred	to	black-bottom	
96-well	microplates,	and	the	relative	caspase-3	activities	were	read	at	
excitation	and	emission	wavelengths	of	380	and	460	nm,	respectively,	in	
a	fluorescence	microplate	reader.	
Statistics	
	Results	are	expressed	as	mean	±	standard	error	of	the	mean.	Differences	
between	cells	and/or	treatments	were	tested	for	statistical	significance	
(p	<0.05)	using	Student’s	unpaired	t	test.	
	
C.	Results	
	Dapagliflozin	mediates	glucose	influx	and	ER	stress	in	HK2	cells.	
Dapagliflozin	inhibits	the	renal	glucose	reabsorption	process	mediated	by	
SGLT2	in	renal	proximal	tubular	epithelial	cells,	thereby	lowering	the	
plasma	blood	glucose	levels	in	patients	with	diabetes10,12,13.	In	order	to	
identify	additional	functions	of	SGLT2,	we	took	advantage	of	HK2	cells,	
an	in	vitro	cell	model	of	renal	proximal	tubular	epithelial	cells.	Firstly,	
we	set	a	series	of	dose	response	and	time	course	experiments	to	determine	
the	effects	of	dapagliflozin	on	glucose	levels	in	HK2	cells.	We	found	that	
glucose	influx	in	cells	treated	with	2μM	dapagliflozin	for	24-48	h	
decreased	by	20%,	compared	to	that	in	control	(non-treated)	cells	(Fig.	
1).	Glucose	influx	mediates	ER	stress	in	cells	and	tissues;	therefore,	we	
next	examined	the	markers	of	ER	stress	in	dapagliflozin-treated	HK-2	cells.	
As	shown	in	Figure	2A	and	2B,	dapagliflozin	decreased	the	phosphorylation	
of	elf2α.	To	confirm	these	data,	we	examined	the	downstream	targets	of	
elf2α.	As	shown	in	Figure	2A,	ATF4	expression	levels	decreased	in	
dapagliflozin-treated	HK2	cells	in	a	way	that	paralleled	the	decrease	in	
eIf2α	phosphorylation	levels.	On	the	other	hand,	dapagliflozin	had	no	
effect	on	total	and	cleaved	forms	of	ATF6	(Fig.	2D	and	E)	or	phosphorylation	
of	IRE1α	(Fig.	2D	and	F),	indicating	that	it	mediated	ER	stress	only	through	
the	elf2α	pathway.	It	has	recently	been	shown	that	CHOP	is	also	a	downstream	
target	of	elf2α,	and	it	has	been	described	as	a	marker	of	ER-mediated	
apoptosis7,9,10.	As	shown	in	Figure	2G,	CHOP	expression	levels	also	decreased	
in	the	dapagliflozin-treated	HK2	cells.	Since	CHOP	expression	levels	
decreased,	we	next	examined	caspase-3	activity	to	determine	the	apoptotic	
status	of	these	cells.	As	shown	in	Figure	2H,	we	observed	a	20%	reduction	
in	caspase-3	activity	in	the	dapagliflozin-treated	cells.	This	paralleled	
the	20%	reduction	in	glucose	influx,	phosphorylation	of	elF2α,	and	
expression	of	CHOP,	suggesting	that	dapagliflozin	might	regulate	apoptosis	
through	the	elf2α-CHOP	axis	in	HK2	cells.	
Dapagliflozin	rescued	C2	ceramide-induced	ER	stress	through	the	elf2α-	
CHOP	pathway	
	Our	data	suggested	that	dapagliflozin	mediated	apoptosis;	however,	
whether	it	could	be	a	key	player	in	the	prevention	of	diabetic	kidney	disease	
remained	to	be	investigated.	Therefore,	in	order	to	examine	
dapagliflozin’s	effect	on	ER	stress	and	apoptosis	in	metabolic	diseases,	
we	focused	on	C2	ceramide,	which	is	not	only	increased	but	also	acts	as	
a	pathogen	in	metabolic	diseases.	As	shown	in	Figure	3,	while	dapagliflozin	
had	no	effect	on	the	expression	of	GLUT2	as	well	as	SGLT2	(Fig.	3A,	B	and	
C),	it	decreased	the	phosphorylation	of	elf2α	(Fig.	3A	and	D)	as	well	as	
the	expression	of	ATF4	(Fig.	3E).	On	the	other	hand,	C2	ceramide	enhanced	
the	phosphorylation	of	elf2α	(Fig.	3A	and	D)	and	the	expression	of	ATF4	
(Fig.	3E).	We	observed	that	dapagliflozin	partially	reduced	these	effects,	
suggesting	that	it	might	participate	in	a	mechanism	that	alleviates	C2	
ceramide-induced	ER	stress.	Importantly,	C2	ceramide-induced	CHOP	
expression	and	caspase-3	activity	was	also	inhibited	by	dapagliflozin	(Fig.	
4A	and	B).	These	data	indicate	dapagliflozin	might	attenuate	the	metabolic	
state	inducing	renal	cell	death	and	has	beneficial	effects	for	preventing	
DN,	independently	of	lowering	of	blood	glucose.	Dapagliflozin	ameliorates	
ER	stress	in	the	kidney	of	db/db	mice	in	vivo.	
	Our	data	suggested	that	dapagliflozin	mediated	ER	stress	and	apoptosis	
in	HK2	cells,	the	model	of	renal	proximal	tubular	epithelial	cells	in	vitro.	
To	further	examine	the	effects,	we	decided	to	repeat	these	series	of	the	
study	by	using	db/db	mouse	kidney.	Previous	reports	have	already	shown	that	
ER	stress	is	upregulated	in	the	kidney	of	db/db	mice,	the	mouse	model	of	
type	2	diabetes22,23.	To	explore	the	effect	of	dapagliflozin	on	ER	stress	
in	the	kidney	of	db/db	mice,	the	drug	was	administered	orally	to	the	animals	
every	day	for	1	week.	Since	dapagliflozin	was	administered	only	for	1	week,	
body	weight	did	not	decrease	significantly	(Fig.	5A),	but	blood	glucose	
levels	significantly	decreased	with	no	significant	change	in	the	expression	
level	of	SGLT2	(Fig.	5B	and	C).	In	these	conditions,	dapagliflozin	decreased	
the	phosphorylation	of	elf2α	(Fig.	5D	and	E)	as	well	as	the	expression	
of	ATF4	(Fig.	5F).	Importantly,	CHOP	expression	and	caspase-3	activity	were	
also	inhibited	by	dapagliflozin	(Fig.	6A	and	B).	These	data	indicate	
dapagliflozin	ameliorates	ER	stress	in	the	kidney	of	db/db	mice	in	vivo	
and	has	beneficial	effects	for	preventing	DN.	
	
D.	Disccusion	
	SGLT2	inhibitors	are	novel	type	2	diabetes	drugs	that	reduce	blood	
glucose	by	inhibiting	SGLT2	in	the	proximal	tubules19,21,24.	Altering	glucose	
influx	into	the	cells	might	contribute	to	the	metabolic	conditions	that	
enhance	the	ER	stress	observed	in	DN.	Therefore,	we	hypothesized	that	
inhibiting	SGLT2	might	reduce	ER	stress	and	protect	against	proximal	
tubular	cell	death.	In	this	study,	we	demonstrated	that	dapagliflozin,	an	
SGLT2	inhibitor,	regulates	ER	stress	by	reducing	the	glucose	concentration	
in	HK-2	cells	and	suppresses	apoptosis	via	the	regulation	of	the	
elf2α-ATF4-CHOP	pathway.	It	was	shown	that	the	anesthetic	drug	propofol	
inhibits	PERK-eIF2α-ATF4-CHOP	activation	under	ER	stress,	caspase-3	
activation,	and	apoptosis,	while	it	activates	the	IRE1-XBP1	and	ATF6	
pathways25.	These	data	indicate	that	the	regulation	of	ER	stress	is	largely	
dependent	on	the	stimulus	itself	and	pathways	regulating	ER	stress	and	
apoptosis	vary	with	the	nature	of	the	cells	and/or	the	pathology.	Our	study	
suggests	that	the	elf2α	-ATF4-CHOP	pathway	regulates	ER	stress	in	the	HK2	
proximal	tubular	cells	as	well	as	in	the	kidney	of	db/db	mice,	a	mouse	model	
of	type	2	diabetes.		
	ER	stress	has	been	associated	with	many	diseases,	including	
neurodegenerative	disorders,	type	2	diabetes,	atherosclerosis,	and	cancer26.	
CHOP	is	one	of	the	key	proteins	playing	a	role	in	apoptosis	induced	by	ER	
stress	and	one	of	the	transcription	factors	regulated	by	both	
PERK-elf2α-ATF4	and	ATF627.	IRE1α	also	induces	apoptosis	through	caspases	
and	ASK1-JNK.	There	was	a	positive	correlation	between	the	enhanced	
expression	of	CHOP	and	cell	apoptosis	in	tubule	epithelial	cells28,	and	
activation	of	PERK	may	be	a	key	event	in	the	regulation	of	CHOP	expression29.	
Our	findings	were	consistent	with	these	data	and	indicated	that	
dapagliflozin	might	regulate	ER	stress-induced	apoptosis	through	the	
PERK-CHOP	axis.	
	Ceramides	are	generated	either	by	the	hydrolysis	of	sphingomyelin	
catalyzed	by	sphingomyelinase	or	by	de	novo	synthesis	in	response	to	
diverse	stimuli.	Under	apoptotic	stimuli,	ceramides	are	generated	by	de	
novo	synthesis	and	promote	activation	of	caspases30,31.	Notably,	ceramides	
are	induced	in	renal	proximal	tubular	cells	in	response	to	hydrogen	peroxide	
or	hypoxia/reperfusion32,33.	Therefore,	we	examined	the	effects	of	
dapaglifozin	on	ER	stress	and	apoptosis	after	C2	ceramide	treatment	and	
demonstrated	that	dapagliflozin	alleviated	renal	cell	death	induced	by	
metabolic	conditions	(i.e.,	increased	glucose	influx).	
	Recently,	evidence	suggested	that	SGLT2	inhibitors	not	only	have	glucose	
lowering	effects	but	might	also	inhibit	the	progression	of	DN34.	For	example,	
empagliflozin	is	the	first	antidiabetic	medication	approved	for	reducing	
the	risk	of	cardiovascular	death	in	patients	with	type	2	diabetes	but	it	
also	reduces	the	effects	of	DN34,35.	Nonetheless,	further	studies	are	
necessary	to	investigate	the	specificity	of	dapagliflozin	for	reducing	the	
effects	of	DN.	In	other	words,	additional	studies	will	be	needed	to	examine	
whether	other	SGLT2	inhibitors	have	potential	beneficial	effects	on	DN	as	
well.	Additional	studies	will	also	be	required	to	determine	whether	
inhibitors	of	other	members	of	the	SGLT	family	might	have	similar	effects	
on	DN.	
	
E.	Summary		
	We	demonstrated	that	dapagliflozin,	a	novel	SGLT2	inhibitor,	lowered	
glucose	influx	in	vitro	and	regulated	ER	stress-mediated	apoptosis	
via	the	regulation	of	the	elf2α-ATF4-CHOP	pathway.	Dapagliflozin	might	
also	partially	reduce	C2	ceramide-induced	ER	stress-mediated	apoptosis,	
which	might	occur	in	DN.	More	importantly	dapagliflozin	ameliorates	ER	
stress	in	the	kidney	of	db/db	mice	in	vivo.	Those	data	suggest	that	
dapagliflozin	might	be	used	for	the	prevention	of	DN	itself.	
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Figure	1	Dapagliflozin	effect	on	glucose	influx	in	HK2	cells                         
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Figure	2	Dapagliflozin	effect	on	ER	stress	in	HK2	cells	
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Figure	3	Dapagliflozin	effect	on	ER	stress	induced	in	HK2	cells	
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Figure	4	Dapagliflozin	effect	on	cell	death	due	to	ER	stress	induced	in	
HK2	cells	
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Figure	5	Dapagliflozin	effect	on	ER	stress	i n	vivo	
A.	Body	weights(g)	of	db/db	mice	
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Figure	6	Dapagliflozin	effect	on	ER	stress-mediated	cell	death	in	vivo	
A.      CHOP/hprt1													B.	Caspase-3	activity(A.U)	
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Figure	1:	Dapagliflogin	regulates	glucose	influx	inside	HK-2	renal	proximal	
tubular	epithelial	cells	
HK2	cells	were	incubated	with	the	indicated	dapagliflozin	concentration	
for	the	indicated	times	and	were	collected	for	glucose	analysis.	Glucose	
concentration	was	assessed	using	the	PicoProbe	Glucose	Fluorometric	Assay	
Kit	(BioVision).	P	<	0.05	(n	=	3-5)	
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Figure	2:	Dapagliflogin	regulates	unfolded	protein	response	(UPR)	in	HK-2	
cells.	
(A)	HK2	cells	were	incubated	with	2μM	dapagliflozin	for	36	h	and	collected	
for	protein	expression	analysis.	These	immunoblots	are	representative	of	
n	=	5	experiments	performed	independently.	(B)	Signal	quantification	of	
the	expression	levels	for	S51	phosphorylation	of	elf2α	normalized	with	
total	elf2α	levels.	(C)	HK2	cells	were	incubated	with	2μM	dapagliflozin	
for	36	h,	and	the	ATF4	mRNA	expression	levels	were	determined	by	qRT-PCR.	
(n	=	5	independent	experiments).	(D)	HK2	cells	were	incubated	with	2μM	
dapagliflozin	for	36	h	and	collected	for	protein	analysis	and	immunoblotted	
for	the	indicated	proteins.	These	are	representative	immunoblots	
independently	performed	five	times.	(E)(F)	Signal	quant１ification	of	the	
expression	levels	of	ATF6	normalized	with	tubulinα	(E)	and	the	expression	
levels	for	S724	phosphorylation	of	IRE1α	normalized	with	total	IRE1α	levels	
(F).	(G)	HK2	cells	were	incubated	with	2μM	dapagliflozin	for	36	h,	and	
the	expression	level	of	CHOP	mRNA	was	determined	by	qRT-PCR.	(n	=	5	
independent	experiments).	(H)	HK2	cells	were	incubated	with	2μM	
dapagliflozin	for	36	h	and	caspase-3	activity	levels	were	measured	using	
a	caspase-3	fluorescence	assay	kit	(MBL)	(n	=	5	independent	experiments)	
Figure	3:	Dapagliflozin	reduces	C2	ceramide	levels	and	increases	UPR	in	
HK2	cells	
(A)	HK2	cells	were	treated	with	2μM	dapagliflozin	for	36	h	with	or	without	
7.5	ng/ml	C2	ceramide,	and	immunoblots	were	performed	with	the	indicated	
antibodies.	(B)(C)	Signal	quantification	of	the	expression	levels	of	GLUT2	
(B)	and	SGLT2	(C)	normalized	with	tubulinα	levels	(D)	Signal	
quantification	of	the	expression	levels	of	S51	phosphorylation	of	elf2α	
normalized	with	total	elf2α	levels.	(E)	HK2	cells	were	incubated	with	2μM	
dapagliflozin	for	36	h,	and	the	mRNA	expression	levels	of	ATF4	were	
determined	by	qRT-PCR	(n=5	independent	experiments).	
Figure	4:	Dapagliflozin	reduces	C2	ceramide	levels	and	increases	apoptosis	
in	HK2	cells	
(A)	HK2	cells	were	incubated	with	2μM	dapagliflozin	for	36	h,	and	the	
expression	levels	of	CHOP	mRNAs	were	determined	by	qRT-PCR	(n=5	
independent	experiments).	(B)	HK2	cells	were	treated	with	2μM	
dapagliflozin	for	36	h	with	or	without	7.5	mM	C2	ceramide,	and	caspase-3	
activity	levels	were	determined	(n	=	5	independent	experiments).	
Figure	5:	The	effect	of	dapagliflogin	on	ER	stress-induced	cell	death	in	
vivo	(A)	Body	weights	of	db/db	mice	administered	oral	dapagliflozin	every	
day	for	1	week.	(B)	Blood	glucose	levels	of	db/db	mice	administered	
dapagliflozin.	(C)	SGLT2	mRNA	levels	in	the	kidney	of	db/db	mice	were	
determined	by	qRT	PCR.	(n=	5	independent	experiments).	(D)(G)	The	kidneys	
of	db/db	mice	were	utilized	for	protein	expression	analysis.	These	
immunoblots	are	representative	of	n	=	5	experiments	performed	independently.	
(E)	Signal	quantification	of	the	expression	levels	of	S51	phosphorylation	
of	elf2α	nor malized	with	total	elf2α.	(F)	Expression	levels	of	ATF4	mRNAs	
were	determined	by	qRT-PCR	(n=	5	independent	experiments).	(H)(I)	Signal	
quantification	of	the	expression	levels	of	ATF6	normalized	with	tubulinα	
(H)	and	the	expression	levels	of	S724	phosphorylation	of	IRE1α	normalized	
with	total	IRE1α	(I).	
Figure	6:	Dapagliflogin	effect	for	ER	stress-mediated	cell	death	in	vivo	
(A)	CHOP	mRNA	levels	in	the	kidney	of	db/db	mice	administered	dapagliflozin	
were	determined	by	qRT-PCR	(n=	5	independent	experiments).	(B)	Caspase-3	
activity	levels	in	the	kidney	of	db/db	mice	administered	dapagliflozin	were	
determined	(n=	5	independent	experiments).	
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